Qube Research & Technologies (QRT)
RVMD icon

Qube Research & Technologies (QRT)’s Revolution Medicines RVMD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.9M Sell
314,365
-238,925
-43% -$34.9M 0.05% 443
2026
Q1 		$53.8M Buy
+553,290
New +$55.9M 0.06% 403
2025
Q3 		– Sell
-786,017
Closed -$28.9M – 3896
2025
Q2 		$28.9M Buy
786,017
+602,877
+329% +$23.2M 0.03% 691
2025
Q1 		$6.48M Sell
183,140
-47,705
-21% -$1.94M 0.01% 1397
2024
Q4 		$10.1M Buy
230,845
+87,771
+61% +$4.43M 0.01% 1080
2024
Q3 		$6.49M Sell
143,074
-106,114
-43% -$4.62M 0.01% 1265
2024
Q2 		$9.67M Buy
249,188
+81,708
+49% +$3.05M 0.02% 936
2024
Q1 		$5.4M Buy
167,480
+141,965
+556% +$4.21M 0.01% 1185
2023
Q4 		$732K Sell
25,515
-192,917
-88% -$4.64M ﹤0.01% 2094
2023
Q3 		$6.05M Buy
+218,432
New +$6.48M 0.02% 853

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RVMD Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Revolution Medicines (RVMD) stake by 43% in Q2 2026, selling an estimated $34.9M and leaving 314,365 shares worth $58.9M. The position accounts for 0.05% of the portfolio, ranked #443.

Qube Research & Technologies (QRT) first reported a position in RVMD in Q3 2023 and has held it in 10 quarters since. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Qube Research & Technologies (QRT) held 314,365 shares of Revolution Medicines worth $58.9M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 238,925 Revolution Medicines shares in Q2 2026, an estimated $34.9M.
  • Revolution Medicines made up 0.05% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #443 holding.
  • Qube Research & Technologies (QRT) first reported a position in Revolution Medicines in Q3 2023 and has held it in 10 quarters since.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.